199 related articles for article (PubMed ID: 24586340)
1. Alanine-glyoxylate aminotransferase 2 (AGXT2) polymorphisms have considerable impact on methylarginine and β-aminoisobutyrate metabolism in healthy volunteers.
Kittel A; Müller F; König J; Mieth M; Sticht H; Zolk O; Kralj A; Heinrich MR; Fromm MF; Maas R
PLoS One; 2014; 9(2):e88544. PubMed ID: 24586340
[TBL] [Abstract][Full Text] [Related]
2. In vivo evidence that Agxt2 can regulate plasma levels of dimethylarginines in mice.
Kittel A; Maas R; König J; Mieth M; Weiss N; Jarzebska N; Hohenstein B; Martens-Lobenhoffer J; Bode-Böger SM; Rodionov RN
Biochem Biophys Res Commun; 2013 Jan; 430(1):84-9. PubMed ID: 23154179
[TBL] [Abstract][Full Text] [Related]
3. AGXT2 and DDAH-1 genetic variants are highly correlated with serum ADMA and SDMA levels and with incidence of coronary artery disease in Egyptians.
Amir M; Hassanein SI; Abdel Rahman MF; Gad MZ
Mol Biol Rep; 2018 Dec; 45(6):2411-2419. PubMed ID: 30284143
[TBL] [Abstract][Full Text] [Related]
4. Diabetes-linked transcription factor HNF4α regulates metabolism of endogenous methylarginines and β-aminoisobutyric acid by controlling expression of alanine-glyoxylate aminotransferase 2.
Burdin DV; Kolobov AA; Brocker C; Soshnev AA; Samusik N; Demyanov AV; Brilloff S; Jarzebska N; Martens-Lobenhoffer J; Mieth M; Maas R; Bornstein SR; Bode-Böger SM; Gonzalez F; Weiss N; Rodionov RN
Sci Rep; 2016 Oct; 6():35503. PubMed ID: 27752141
[TBL] [Abstract][Full Text] [Related]
5. Missense variants of the alanine:glyoxylate aminotransferase 2 gene are not associated with Japanese schizophrenia patients.
Yoshino Y; Abe M; Numata S; Ochi S; Mori Y; Ishimaru T; Kinoshita M; Umehara H; Yamazaki K; Mori T; Ohmori T; Ueno S
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():137-41. PubMed ID: 24727203
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations in the alanine-glyoxylate aminotransferase 2 (AGXT2) gene and dimethylarginines levels in rheumatoid arthritis.
Dimitroulas T; Hodson J; Panoulas VF; Sandoo A; Smith J; Kitas G
Amino Acids; 2017 Jun; 49(6):1133-1141. PubMed ID: 28357606
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide association study on dimethylarginines reveals novel AGXT2 variants associated with heart rate variability but not with overall mortality.
Seppälä I; Kleber ME; Lyytikäinen LP; Hernesniemi JA; Mäkelä KM; Oksala N; Laaksonen R; Pilz S; Tomaschitz A; Silbernagel G; Boehm BO; Grammer TB; Koskinen T; Juonala M; Hutri-Kähönen N; Alfthan G; Viikari JS; Kähonen M; Raitakari OT; März W; Meinitzer A; Lehtimäki T;
Eur Heart J; 2014 Feb; 35(8):524-31. PubMed ID: 24159190
[TBL] [Abstract][Full Text] [Related]
8. Effects of AGXT2 variants on blood pressure and blood sugar among 750 older Japanese subjects recruited by the complete enumeration survey method.
Yoshino Y; Kumon H; Mori T; Yoshida T; Tachibana A; Shimizu H; Iga JI; Ueno SI
BMC Genomics; 2021 Apr; 22(1):287. PubMed ID: 33879046
[TBL] [Abstract][Full Text] [Related]
9. Role of alanine:glyoxylate aminotransferase 2 in metabolism of asymmetric dimethylarginine in the settings of asymmetric dimethylarginine overload and bilateral nephrectomy.
Rodionov RN; Martens-Lobenhoffer J; Brilloff S; Hohenstein B; Jarzebska N; Jabs N; Kittel A; Maas R; Weiss N; Bode-Böger SM
Nephrol Dial Transplant; 2014 Nov; 29(11):2035-42. PubMed ID: 25002409
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine.
Lüneburg N; Lieb W; Zeller T; Chen MH; Maas R; Carter AM; Xanthakis V; Glazer NL; Schwedhelm E; Seshadri S; Ikram MA; Longstreth WT; Fornage M; König IR; Loley C; Ojeda FM; Schillert A; Wang TJ; Sticht H; Kittel A; König J; Benjamin EJ; Sullivan LM; Bernges I; Anderssohn M; Ziegler A; Gieger C; Illig T; Meisinger C; Wichmann HE; Wild PS; Schunkert H; Psaty BM; Wiggins KL; Heckbert SR; Smith N; Lackner K; Lunetta KL; Blankenberg S; Erdmann J; Munzel T; Grant PJ; Vasan RS; Böger RH
Circ Cardiovasc Genet; 2014 Dec; 7(6):864-72. PubMed ID: 25245031
[TBL] [Abstract][Full Text] [Related]
11. Considerable impacts of AGXT2 V140I polymorphism on chronic heart failure in the Chinese population.
Hu XL; Zhou JP; Kuang DB; Qi H; Peng LM; Yang TL; Li X; Zhang W; Zhou HH; Chen XP
Atherosclerosis; 2016 Aug; 251():255-262. PubMed ID: 27423328
[TBL] [Abstract][Full Text] [Related]
12. AGXT2: An unnegligible aminotransferase in cardiovascular and urinary systems.
Hu XL; Li MP; Song PY; Tang J; Chen XP
J Mol Cell Cardiol; 2017 Dec; 113():33-38. PubMed ID: 28970090
[TBL] [Abstract][Full Text] [Related]
13. Alanine-glyoxylate aminotransferase-2 metabolizes endogenous methylarginines, regulates NO, and controls blood pressure.
Caplin B; Wang Z; Slaviero A; Tomlinson J; Dowsett L; Delahaye M; Salama A; ; Wheeler DC; Leiper J
Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2892-900. PubMed ID: 23023372
[TBL] [Abstract][Full Text] [Related]
14. Missense variants of the alanine: glyoxylate aminotransferase 2 gene correlated with carotid atherosclerosis in the Japanese population.
Yoshino Y; Kohara K; Abe M; Ochi S; Mori Y; Yamashita K; Igase M; Tabara Y; Mori T; Miki T; Ueno S
J Biol Regul Homeost Agents; 2014; 28(4):605-14. PubMed ID: 25620171
[TBL] [Abstract][Full Text] [Related]
15. Cats with Genetic Variants of AGXT2 Respond Differently to a Dietary Intervention Known to Reduce the Risk of Calcium Oxalate Stone Formation.
Hall JA; Panickar KS; Brockman JA; Jewell DE
Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627178
[TBL] [Abstract][Full Text] [Related]
16. Association of the AGXT2 V140I polymorphism with risk for coronary heart disease in a Chinese population.
Zhou JP; Bai YP; Hu XL; Kuang DB; Shi RZ; Xiong Y; Zhang W; Xia J; Chen BL; Yang TL; Chen XP
J Atheroscler Thromb; 2014; 21(10):1022-30. PubMed ID: 24834905
[TBL] [Abstract][Full Text] [Related]
17. Functional AGXT2 SNP rs37369 Variant Is a Risk Factor for Diabetes Mellitus: Baseline Data From the Aidai Cohort Study in Japan.
Kumon H; Miyake Y; Yoshino Y; Iga JI; Tanaka K; Senba H; Kimura E; Higaki T; Matsuura B; Kawamoto R; Ueno SI
Can J Diabetes; 2022 Dec; 46(8):829-834. PubMed ID: 35961823
[TBL] [Abstract][Full Text] [Related]
18. Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production.
Rodionov RN; Murry DJ; Vaulman SF; Stevens JW; Lentz SR
J Biol Chem; 2010 Feb; 285(8):5385-91. PubMed ID: 20018850
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of alanine-glyoxylate aminotransferase 2 protects from asymmetric dimethylarginine-induced endothelial dysfunction and aortic remodeling.
Rodionov RN; Jarzebska N; Burdin D; Todorov V; Martens-Lobenhoffer J; Hofmann A; Kolouschek A; Cordasic N; Jacobi J; Rubets E; Morawietz H; O'Sullivan JF; Markov AG; Bornstein SR; Hilgers K; Maas R; Pfluecke C; Chen Y; Bode-Böger SM; Hugo CPM; Hohenstein B; Weiss N
Sci Rep; 2022 Jun; 12(1):9381. PubMed ID: 35672381
[TBL] [Abstract][Full Text] [Related]
20. The role of alanine glyoxylate transaminase-2 (agxt2) in β-alanine and carnosine metabolism of healthy mice and humans.
Stautemas J; Jarzebska N; Shan ZX; Blancquaert L; Everaert I; de Jager S; De Baere S; Hautekiet A; Volkaert A; Lefevere FBD; Martens-Lobenhoffer J; Bode-Böger SM; Kim CK; Leiper J; Weiss N; Croubels S; Rodionov RN; Derave W
Eur J Appl Physiol; 2020 Dec; 120(12):2749-2759. PubMed ID: 32948897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]